The Economic Burden of Insulin Injection-Induced Lipohypertophy. Role of Education: The ISTERP-3 Study.
Sandro GentileGiuseppina GuarinoTeresa Della CorteGiampiero MarinoErsilia SattaMaria PasquarellaCarmine RomanoCarmelo AlfroneLaura GiordanoFabrizio LoiaconoMaurizio CapeceRossella LambertiFelice Strollonull nullPublished in: Advances in therapy (2022)
The effect of only initial education in the CG was not significant, thus providing evidence of the virtual worthlessness of a single training session on injection techniques, typical of worldwide daily clinical practice, and easily explaining the extremely high prevalence of LH in insulin-treated patients. Conversely, highly positive effects on LH prevalence and size as well as costs expected from decreased HYPO rate were obtained in the IG. To our knowledge, ours is the first 18-month randomized trial in the field. If our experimental model were to be used as an effective, longstanding behavioral rehabilitation strategy and therefore adapted to real-world settings universally, LH prevalence and costs related to their clinical consequences would be drastically reduced. However, only with a strong, relentless commitment of universities, scientific societies, and patient associations can we achieve this ambitious goal, which would provide great institutional savings and improved quality of life for people with diabetes.
Keyphrases
- type diabetes
- healthcare
- glycemic control
- clinical practice
- end stage renal disease
- newly diagnosed
- risk factors
- ejection fraction
- chronic kidney disease
- cardiovascular disease
- quality improvement
- ultrasound guided
- physical activity
- case report
- high glucose
- diabetic rats
- metabolic syndrome
- drug induced
- insulin resistance
- patient reported